Atara's Pascal Touchon on allo
Atara Biotherapeutics' CEO Pascal Touchon discusses his company's approved allogeneic cell therapy, and the EBV theory of multiple sclerosis.
Also look for unique social pages for BiotechTV U.
The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants
Comments